(Q43406255)

23 November 2017

Management of myeloma kidney: an anti-light-chain approach (English)

1 reference

23 November 2017

1 reference

Misiani R

1

1 reference

23 November 2017

Tiraboschi G

series ordinal

2

1 reference

23 November 2017

Mingardi G

series ordinal

3

1 reference

23 November 2017

Mecca G

series ordinal

4

1 reference

23 November 2017

1 July 1987

1 reference

American Journal of Kidney Diseases

23 November 2017

1 reference

23 November 2017

10

1 reference

23 November 2017

1

1 reference

23 November 2017

28-33

1 reference

Renal function in patients with multiple myeloma

23 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980007-0

7 January 2021

Bence-Jones proteins and light chains of immunoglobulins (first of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980007-0

7 January 2021

Pathogenesis of Renal Disease in Monoclonal Gammopathies: Current Concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980007-0

7 January 2021

Plasmapheresis in the treatment of acute renal failure in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980007-0

7 January 2021

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980007-0

7 January 2021

Renal complications in multiple myeloma: Pathophysiology and some aspects of clinical management

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980007-0

7 January 2021

Bence Jones proteins: malignant or benign?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980007-0

7 January 2021

Acute renal failure in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980007-0

7 January 2021

The treatment of plasma cell myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980007-0

7 January 2021

Combination therapy for multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980007-0

7 January 2021

Long-term survival in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980007-0

7 January 2021

Free light chains of immunoglobulins in serum from patients with leukaemias and multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980007-0

7 January 2021

METABOLISM OF BENCE JONES PROTEINS.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980007-0

7 January 2021

The role of the kidney in the catabolism of Bence Jones proteins and immunoglobulin fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980007-0

7 January 2021

Plasma exchange v peritoneal dialysis for removing Bence Jones protein

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980007-0

7 January 2021

Acute renal failure in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980007-0

7 January 2021

Should patients with renal failure associated with myeloma be dialysed?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980007-0

7 January 2021

Acute renal failure in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980007-0

7 January 2021

Clinical Staging in Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980007-0

7 January 2021

Factors influencing the prognosis in myelomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2887%2980007-0

7 January 2021

10.1016/S0272-6386(87)80007-0

Identifiers

DOI

1 reference

23 November 2017

1 reference